Cagrilintide
Investigational amylin analog in clinical trials. Not FDA-approved.
- Type
- Peptide
- Research area
- Metabolic research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About Cagrilintide
Investigational amylin analog in clinical trials. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is Cagrilintide an FDA-approved medicine?
No. Cagrilintide is not an FDA-approved medicine. Research stage: Clinical trials.
Does EKO Labs sell Cagrilintide?
No. EKO Labs does not sell Cagrilintide or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use Cagrilintide?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
What is the molecular formula of Cagrilintide?
According to PubChem (U.S. National Library of Medicine), Cagrilintide has the molecular formula C194H312N54O59S2 and a molar mass of about 4,409.0 g/mol.
The molecule: Cagrilintide
Drag to rotate. Every atom and bond below comes from the public PubChem database of the U.S. National Institutes of Health; nothing is drawn by AI.
- Formula
- C194H312N54O59S2
- Molar mass
- 4,409.0 g/mol
- Heavy atoms
- 309
- PubChem CID
- 171397054 ↗
Source: PubChem, National Library of Medicine (public domain).
Related compounds
C192H289N47O61SurvodutideSurvodutide
Investigational medicine in clinical trials. Not FDA-approved.
C101H152N28O22S2MOTS-cMOTS-c
A mitochondria-derived peptide studied in metabolic research.
C78H123N23O23S2AOD-9604AOD-9604
A growth-hormone fragment studied in metabolism research.